Elevated urinary level of vitamin D-binding protein as a novel biomarker for diabetic nephropathy

Experimental and Therapeutic Medicine

Volumn 7, Issue 2, 2014, Pages 411-416

  Tian, Xiao Qin ^a   Zhao, Li Min ^b   Ge, Jia Pu ^b   Zhang, Yan ^c   Xu, Yan Cheng ^a  

^a WUHAN UNIVERSITY   (China)

^b Xinjiang Uygur Autonomous Region Hospital   (China)

^c XINJIANG MEDICAL UNIVERSITY   (China)

Author keywords

Diabetic nephropathy; Urine; Vitamin D binding protein

Indexed keywords

CREATININE; VITAMIN D BINDING PROTEIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; URINALYSIS; WESTERN BLOTTING;

EID: 84890471410     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2013.1426     Document Type: Article

References (30)

1. Hu FB, Manson JE, Stampfer MJ, Colditz G, Liu S, Solomon CG and Willett WC: Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med 345: 790-797, 2001.
2. Pittas AG, Lau J, Hu FB and Dawson-Hughes B: The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 92: 2017-2029, 2007.
3. Iso H: Changes in coronary heart disease risk among Japanese. Circulation 118: 2725-2729, 2008.
4. Valmadrid CT, Klein R, Moss SE and Klein BE: The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus. Arch Intern Med 160: 1093-1100, 2000.
5. Wild S, Roglic G, Green A, Sicree R and King H: Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27: 1047-1053, 2004.
6. Tabaei BP, Al-Kassab AS, Ilag LL, Zawacki CM and Herman WH: Does microalbuminuria predict diabetic nephropathy? Diabetes Care 24: 1560-1566, 2001.
7. Jiang H, Guan G, Zhang R, Liu G, Cheng J, Hou X and Cui Y: Identification of urinary soluble E-cadherin as a novel biomarker for diabetic nephropathy. Diabetes Metab Res Rev 25: 232-241, 2009.
8. Li F, Chen DN, He CW, Zhou Y, Olkkonen VM, He N, Chen W, Wan P, Chen SS, Zhu YT, Lan KJ and Tan WL: Identification of urinary Gc-globulin as a novel biomarker for bladder cancer by two-dimensional fluorescent differential gel electrophoresis (2D-DIGE). J Proteomics 77: 225-236, 2012.
9. Thrailkill KM, Jo CH, Cockrell GE, Moreau CS and Fowlkes JL: Enhanced excretion of vitamin D binding protein in type 1 diabetes: a role in vitamin D deficiency? J Clin Endocrinol Metab 96: 142-149, 2011.
10. Cho S, Choi YS, Yim SY, Yang HI, Jeon YE, Lee KE, Kim H, Seo SK and Lee BS: Urinary vitamin D-binding protein is elevated in patients with endometriosis. Hum Reprod 27: 515-522, 2012.
11. Hanley JA and McNeil BJ: The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143: 29-36, 1982.
12. Jiang H, Guan G, Zhang R, Liu G, Liu H, Hou X and Cheng J: Increased urinary excretion of orosomucoid is a risk predictor of diabetic nephropathy. Nephrology (Carlton) 14: 332-337, 2009.
13. Dihazi H and Müller GA: Urinary proteomics: a tool to discover biomarkers of kidney diseases. Expert Rev Proteomics 4: 39-50, 2007.
14. Varghese SA, Powell TB, Budisavljevic MN, Oates JC, Raymond JR, Almeida JS and Arthur JM: Urine biomarkers predict the cause of glomerular disease. J Am Soc Nephrol 18: 913-922, 2007.
15. Cooke NE and David EV: Serum vitamin D-binding protein is a third member of the albumin and alpha fetoprotein gene family. J Clin Invest 76: 2420-2424, 1985.
16. Chun RF, Peercy BE, Adams JS and Hewison M: Vitamin D binding protein and monocyte response to 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D: analysis by mathematical modeling. PLoS One 7: e30773, 2012.
17. Christakos S, Ajibade DV, Dhawan P, Fechner AJ and Mady LJ: Vitamin D: metabolism. Endocrinol Metab Clin North Am 39: 243-253, 2010.
18. Yamamoto N and Naraparaju VR: Vitamin D3-binding protein as a precursor for macrophage activating factor in the inflammation-primed macrophage activation cascade in rats. Cell Immunol 170: 161-167, 1996.
19. Gregory KJ, Zhao B, Bielenberg DR, Dridi S, Wu J, Jiang W, Huang B, Pirie-Shepherd S and Fannon M: Vitamin D binding protein-macrophage activating factor directly inhibits proliferation, migration, and uPAR expression of prostate cancer cells. PLoS One 5: e13428, 2010.
20. Yamamoto N, Naraparaju VR and Asbell SO: Deglycosylation of serum vitamin D3-binding protein leads to immunosuppression in cancer patients. Cancer Res 56: 2827-2831, 1996.
21. Yamamoto N, Suyama H, Nakazato H, Yamamoto N and Koga Y: Immunotherapy of metastatic colorectal cancer with vitamin D-binding protein-derived macrophage-activating factor, GcMAF. Cancer Immunol Immunother 57: 1007-1016, 2008.
22. Nykjaer A, Dragun D, Walther D, Vorum H, Jacobsen C, Herz J, Melsen F, Christensen EI and Willnow TE: An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3. Cell 96: 507-515, 1999.
23. 3-1α-hydroxylase. J Clin Endocrinol Metab 86: 888-894, 2001.
24. Colston K, Williams NJ and Cleeve HJ: Studies on vitamin D binding protein in the nephrotic syndrome. Clin Chem 31: 718-721, 1985.
25. Vilasi A, Cutillas PR, Maher AD, Zirah SF, Capasso G, Norden AW, Holmes E, Nicholson JK and Unwin RJ: Combined proteomic and metabonomic studies in three genetic forms of the renal Fanconi syndrome. Am J Physiol Renal Physiol 293: F456-F467, 2007.
26. Uchida M, Teranishi H, Aoshima K, Katoh T, Kasuya M and Inadera H: Elevated urinary levels of vitamin D-binding protein in the inhabitants of a cadmium polluted area, Jinzu River basin, Japan. Tohoku J Exp Med 211: 269-274, 2007.
27. Svoren BM, Volkening LK, Wood JR and Laffel LM: Significant vitamin D deficiency in youth with type 1 diabetes mellitus. J Pediatr 154: 132-134, 2009.
28. Tahrani AA, Ball A, Shepherd L, Rahim A, Jones AF and Bates A: The prevalence of vitamin D abnormalities in South Asians with type 2 diabetes mellitus in the UK. Int J Clin Pract 64: 351-355, 2010.
29. Mirković K, Doorenbos CR, Dam WA, Lambers Heerspink HJ, Slagman MC, Nauta FL, Kramer AB, Gansevoort RT, van den Born J, Navis G and de Borst MH: Urinary vitamin D binding protein: a potential novel marker of renal interstitial inflammation and fibrosis. PLoS One 8: e55887, 2013.
30. Zoidakis J, Makridakis M, Zerefos PG, Bitsika V, Esteban S, Frantzi M, Stravodimos K, Anagnou NP, Roubelakis MG, Sanchez-Carbayo M and Vlahou A: Profilin 1 is a potential biomarker for bladder cancer aggressiveness. Mol Cell Proteomics 11: M111.009449, 2012.